These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 1906534)

  • 1. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Ohman J; Servo A; Heiskanen O
    J Neurosurg; 1991 Aug; 75(2):197-201. PubMed ID: 1906535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm.
    Kinugasa K; Kamata I; Hirotsune N; Tokunaga K; Sugiu K; Handa A; Nakashima H; Ohmoto T; Mandai S; Matsumoto Y
    J Neurosurg; 1995 Jul; 83(1):34-41. PubMed ID: 7782847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms.
    Górski R; Zabek M; Jarmuzek P
    Neurol Neurochir Pol; 2000; 34(6 Suppl):41-7. PubMed ID: 11452854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovations in aneurysmal subarachnoid hemorrhage: intracisternal t-PA for the prevention of vasospasm.
    Bell TE; Kongable GL
    J Neurosci Nurs; 1996 Apr; 28(2):107-13. PubMed ID: 8718759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study.
    Stolke D; Seifert V
    Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of intracisternal tissue plasminogen activator to prevent vasospasm in certain patients with aneurysmal subarachnoid hemorrhage.
    Steinberg GK; Vanefsky MA; Marks MP; Adler JR; Koenig GH
    Neurosurgery; 1994 May; 34(5):809-13; discussion 813-4. PubMed ID: 8052377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Sasaki T; Ohta T; Kikuchi H; Takakura K; Usui M; Ohnishi H; Kondo A; Tanabe H; Nakamura J; Yamada K
    Neurosurgery; 1994 Oct; 35(4):597-604; discussion 604-5. PubMed ID: 7808602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracisternal rt-PA during early surgery for aneurysmal subarachnoid hemorrhage: an Italian report.
    Tomasello F; D'Avella D
    J Neurosurg Sci; 1993 Jun; 37(2):71-5. PubMed ID: 8301373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage.
    Kinouchi H; Ogasawara K; Shimizu H; Mizoi K; Yoshimoto T
    Neurol Med Chir (Tokyo); 2004 Nov; 44(11):569-75; discussion 576-7. PubMed ID: 15686175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator.
    Mizoi K; Yoshimoto T; Takahashi A; Fujiwara S; Koshu K; Sugawara T
    J Neurosurg; 1993 Mar; 78(3):430-7. PubMed ID: 8433145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.
    Lasner TM; Weil RJ; Riina HA; King JT; Zager EL; Raps EC; Flamm ES
    J Neurosurg; 1997 Sep; 87(3):381-4. PubMed ID: 9285602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis for intraventricular hemorrhage after endovascular aneurysmal coiling.
    Hall B; Parker D; Carhuapoma JR
    Neurocrit Care; 2005; 3(2):153-6. PubMed ID: 16174886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of cerebral vasospasm after endovascular treatment of acutely ruptured aneurysms: report on 69 cases.
    Murayama Y; Malisch T; Guglielmi G; Mawad ME; Viñuela F; Duckwiler GR; Gobin YP; Klucznick RP; Martin NA; Frazee J
    J Neurosurg; 1997 Dec; 87(6):830-5. PubMed ID: 9384391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
    Usui M; Saito N; Hoya K; Todo T
    Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.
    Findlay JM; Jacka MJ
    Neurosurgery; 2004 Sep; 55(3):532-7; discussion 537-8. PubMed ID: 15335420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.